New 4-Atom Staple Controls 3₁₀-Helix Shape and Direction in Peptide Drugs | Research

The takeaway

Stereochemically configured 4-atom hydrocarbon staples effectively stabilize right-handed 3₁₀-helices in peptides, with the Ri,i+3S(4) configuration being optimal for natural amino acid sequences.

Ri,i+3S(4)
optimal staple configuration for stabilizing right-handed 3₁₀-helices with natural amino acids

What the researchers found

The Ri,i+3S(4) staple configuration strongly induces right-handed 3₁₀-helices in peptides with natural L-amino acids, with the staple's stereochemistry being critical for both helix stabilization and screw sense control.

Why it matters

3₁₀-helices are involved in many important protein interactions but have been difficult to reproduce in synthetic peptides. This technology enables drug designers to create stable 3₁₀-helical peptides that can mimic these interactions, expanding the structural toolbox for peptide therapeutics.

The numbers in context

4-atom hydrocarbon staples used; circular dichroism spectroscopy confirmed helix stability and screw sense control.

How the study worked

Synthesis of stereochemically defined 4-atom hydrocarbon staples via ring-closing metathesis, with circular dichroism spectroscopy to assess 3₁₀-helix formation and screw sense across different configurations and peptide sequences.

Who was studied

Synthetic peptides — no biological subjects

What this study cannot tell us

Demonstrated with model peptides — therapeutic target engagement not tested; CD spectroscopy provides ensemble structure but not atomic-level detail; in vivo stability and cell permeability not assessed; limited to sequences compatible with staple positions.

How to read the evidence

Preliminary proof-of-concept for a novel peptide stabilization technology. Well-characterized by CD spectroscopy but lacking biological validation.

When this study was published

Published in 2024, addressing an unmet need in peptide drug design for 3₁₀-helix stabilization.

The bigger picture

While α-helix stapling has received most attention in peptide drug design, 3₁₀-helices play distinct biological roles. This work fills a critical gap by providing the first systematic approach to stabilizing 3₁₀-helices with defined stereochemistry.

Questions still open

Can 3₁₀-helix-stabilized peptides disrupt protein-protein interactions that α-helix staples cannot?
How do these stapled peptides perform in terms of cell permeability and metabolic stability?
What disease-relevant targets have 3₁₀-helix binding interfaces that this technology could exploit?

Common questions

What is a 3₁₀-helix and why is it hard to make?

It's a tighter, more compact version of the common helix found in proteins. Unlike the α-helix (which has well-established stabilization methods), the 3₁₀-helix has been very difficult to stabilize in synthetic peptides — until this study developed stereochemically defined staples for it.

How could this help create new drugs?

Many important protein interactions involve 3₁₀-helices. By being able to lock peptide drugs into this specific shape, researchers can design molecules that mimic or block these interactions more precisely — potentially creating new treatments for diseases where current drugs can't reach.

Read the original research

310-Helix stabilization and screw sense control via stereochemically configured 4-atom hydrocarbon staples.

Bioorganic & medicinal chemistry, 114, 117963

View on PubMed ↗Publisher’s paper ↗

Citation

Tran, Duc V H; Nguyen, Ha T N; Ahn, Hee-Chul; Kim, Young-Woo. (2024). 310-Helix stabilization and screw sense control via stereochemically configured 4-atom hydrocarbon staples.. Bioorganic & medicinal chemistry, 114, 117963. https://doi.org/10.1016/j.bmc.2024.117963